P1156 DACLATASVIR, ASUNAPREVIR, AND BMS-791325 IN A FIXED-DOSE COMBINATION: A PHASE 1 BIOAVAILABILITY STUDY IN HEALTHY VOLUNTEERS
2014 ◽
Vol 60
(1)
◽
pp. S468-S469
◽
Keyword(s):
Phase 1
◽
2014 ◽
Vol 34
(5)
◽
pp. 335-349
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 24
(6)
◽
pp. 1703-1709
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 24
(4)
◽
pp. 175
◽
Keyword(s):
2015 ◽
Vol 53
(01)
◽
pp. 66-74
Keyword(s):